Vertaling van "corporate –268 –215 " (Frans → Nederlands) :

T4 2009 T3 2009 Variation M USD M USD M USD % Pharmaceuticals 2 215 2 364 –149 –6 Vaccins et Diagnostic 653 102 551 NS Sandoz 356 385 –29 –8 Consumer Health 248 323 –75 –23 Produits/charges nets de Corporate –268 –215 –53 25 Résultat opérationnel « core » 3 204 2 959 245 8
Q4 2009 Q3 2009 Change USD m USD m USD m % Pharmaceuticals 2 215 2 364 –149 –6 Vaccines and Diagnostics 653 102 551 NM Sandoz 356 385 –29 –8 Consumer Health 248 323 –75 –23 Corporate Income & Expense, net –268 –215 –53 25 Core operating income 3 204 2 959 245 8

T1 2010 T4 2009 Variation M USD M USD M USD % Pharmaceuticals 2 431 2 215 216 10 Vaccins et Diagnostic 923 653 270 41 Sandoz 450 356 94 26 Consumer Health 288 248 40 16 Produits/charges nets de Corporate –227 –268 41 –15 Résultat opérationnel core 3 865 3 204 661 21
Q1 2010 Q4 2009 Change USD m USD m USD m % Pharmaceuticals 2 431 2 215 216 10 Vaccines and Diagnostics 923 653 270 41 Sandoz 450 356 94 26 Consumer Health 288 248 40 16 Corporate Income & Expense, net –227 –268 41 –15 Core operating income 3 865 3 204 661 21